Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Silberstein SD et al. – Scheduled short–term preventive frovatriptan therapy effectively reduced the occurrence of menstrual migraine in women with attacks occurring exclusively in association with menstruation.

Related Articles

Safety and Tolerability of Short-Term Preventive Frovatriptan: A Combined Analysis
Headache: The Journal of Head and Face Pain, 10/15/09    Relevance Score: 89%

Clinical and Economic Comparison of Frovatriptan Versus other Oral Triptans in the Treatment of Acute Migraine in the Real-World Setting
Clinical Drug Investigation, 10/15/09    Relevance Score: 81%

Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination
Current Medical Research and Opinion, 10/01/09    Relevance Score: 80%

Increased Dopamine Is Associated With the cGMP and Homocysteine Pathway in Female Migraineurs
Headache: The Journal of Head and Face Pain, 10/07/09    Relevance Score: 78%

Menstrual migraine pattern may start in adolescence
Internet Source, 11/12/09    Relevance Score: 70%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address